PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 1,300 shares, an increase of 225.0% from the December 31st total of 400 shares. Based on an average daily volume of 53,100 shares, the days-to-cover ratio is presently 0.0 days.
PURE Bioscience Price Performance
Shares of PURE stock remained flat at $0.12 during mid-day trading on Thursday. The company's stock had a trading volume of 89,898 shares, compared to its average volume of 26,700. PURE Bioscience has a 12 month low of $0.07 and a 12 month high of $0.24. The firm's 50-day moving average price is $0.12 and its two-hundred day moving average price is $0.17. The company has a market capitalization of $13.36 million, a PE ratio of -3.00 and a beta of 0.07.
Get PURE Bioscience alerts:PURE Bioscience (OTCMKTS:PURE – Get Rating) last released its quarterly earnings results on Friday, October 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. PURE Bioscience had a negative return on equity of 135.85% and a negative net margin of 206.26%. The company had revenue of $0.40 million for the quarter.
Hedge Funds Weigh In On PURE Bioscience
A hedge fund recently bought a new stake in PURE Bioscience stock. IFG Advisory LLC purchased a new position in shares of PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 809,809 shares of the company's stock, valued at approximately $161,000. IFG Advisory LLC owned about 0.92% of PURE Bioscience as of its most recent SEC filing. 0.92% of the stock is currently owned by institutional investors and hedge funds.About PURE Bioscience
(Get Rating)
PURE Bioscience, Inc engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.
See Also
- Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
- The Future Of E-Commerce: Analysis And New Data
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- Levi Strauss Is A Good Fit For Income Investors
- 3 Small Caps That Have Big Upside
- Mullen Automotive: The Good News, The Bad And The Ugly Outlook
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.